Login
$CLRB
$1.21 +$0.00 (0.0%) Close

$CLRB 3 SEC Filings

Filed On Filing
09 Jun 2026 Form 3: Gu Andrew, Director

No securities owned

16 Mar 2023 Form 3: Shustov Andrei, Senior Vice President, Medical

Holds 7,181.7 shares of Common Stock

15 Dec 2022 Form 3: Lea Darrell Shane, Chief Commercial Officer

No securities owned

24 Feb 2022 Form 3: Kolean Chad J, Chief Financial Officer

No securities owned

02 Jul 2021 Form 3: Chanan-Khan Asher, Director

No securities owned

06 Jul 2020 Form 3: Friend John E. Ii, VP, Chief Medical Officer

Holds 3,333 shares of Common Stock

08 Jan 2020 Form 3: Grachev Igor D, Chief Medical Officer

No securities owned

11 Sep 2019 Form 3: Elefant Dov, Chief Financial Officer

No securities owned

11 Mar 2019 Form 3: Bernhardt Charles Thomas Iii, Interim CFO

No securities owned

05 Apr 2018 Form 3: Posner Brian M, Chief Financial Officer

No securities owned

08 Sep 2017 Form 3: Hamill John P., Interim CFO

No securities owned

18 Apr 2017 Form 3: Friend John E. Ii, VP, Chief Medical Officer

No securities owned

18 Apr 2017 Form 3: Swirsky Douglas J, Director

No securities owned

18 Apr 2017 Form 3: Driscoll Frederick W, Director

No securities owned

12 Aug 2016 Form 3: Longcor Jarrod, Sr. VP of Corp Dev & Ops

No securities owned

25 Apr 2016 Form 3: Wisconsin Alumni Research Foundation, 10% owner

Holds 469,484 shares of Common Stock

05 Aug 2015 Form 3: Loren Stefan, Director
04 Aug 2015 Form 3: Caruso James V, Director
18 Dec 2014 Form 3: Szakacs Cameron, VP of Clinical Development

No securities owned

08 Sep 2014 Form 3: Marxe Austin W & Greenhouse David M, 10% owner

Holds 1,066,000 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support